Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Rating of “Buy” from Brokerages
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have received an average rating of “Buy” from the five ratings firms that are currently covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have covered the stock in […]
More Stories
Versarien (LON:VRS) Shares Up 3.4% – Here’s Why
Versarien plc (LON:VRS – Get Free Report)’s share price shot up 3.4% on Monday . The company traded as high...
Ennis (NYSE:EBF) Releases Earnings Results, Meets Estimates
Ennis (NYSE:EBF – Get Free Report) announced its quarterly earnings results on Monday. The industrial products company reported $0.39 EPS...
Head-To-Head Survey: Shopify (NYSE:SHOP) versus Ceridian HCM (NYSE:CDAY)
Shopify (NYSE:SHOP – Get Free Report) and Ceridian HCM (NYSE:CDAY – Get Free Report) are both large-cap computer and technology...
Botswana Diamonds (LON:BOD) Stock Price Up 36.9% – Time to Buy?
Botswana Diamonds plc (LON:BOD – Get Free Report) shares were up 36.9% on Monday . The stock traded as high...
Thermo Fisher Scientific (NYSE:TMO) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank assumed coverage on shares of Thermo Fisher Scientific (NYSE:TMO – Get Free Report) in a...
Rhythm Pharmaceuticals (NASDAQ:RYTM) Given “Market Outperform” Rating at JMP Securities
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “market outperform” rating restated by stock analysts at JMP Securities...